太阳制药因拟以117.5亿美元收购Organon & Co获得穆迪和标普评级上调
· economictimes.indiatimes.com
评级机构穆迪和标普授予太阳制药工业投资级评级。此举是在太阳制药提议收购美国Organon & Co之后作出的。该交易预计将显著增强太阳制药的业务地位和收入基础。收购后，Organon将为集团收益做出重大贡献。这一战略举措将提升太阳制药的规模和地理覆盖范围。
Live Events
as a Reliable and Trusted News Source Addas a Reliable and Trusted News Source Add Now!
(You can now subscribe to our
(You can now subscribe to...